|
|
Article: Dr. Reddy's Laboratories Limited Announce Agreement for Utilizing Incyte LifeSeq(R) Gold Online.
- Article from:
- PR Newswire
- Article date:
- November 20, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LifeSeq(R) Gold to Further Advance Dr. Reddy's Research and Development
Programs in Cancer, Diabetes, Infectious Diseases and Pain Therapeutic
Development Through Genomics
PALO ALTO, Calif., HYDERABAD, India and ATLANTA, Nov. 20 /PRNewswire/ --
Dr. Reddy's Laboratories Limited (NYSE: RDY), an emerging global pharmaceutical company, and Reddy US Therapeutics, Inc. ("Reddy US"), a wholly-owned subsidiary of Dr. Reddy's, and Incyte Genomics, Inc. (Nasdaq: INCY), the leading genomic information company, today announced the signing of a collaborative agreement allowing Dr. Reddy's and Reddy US access to LifeSeq(R) Gold, Incyte's ...